ANGPTL4 Antibody 4 Publications

Rabbit Polyclonal| Catalog number: 18374-1-AP

  • Print page
  • Download PDF

Be the first to review this product



Con: 43 μg/150 μl

Choose size:

Please visit your regions distributor:

Species specificity:
human, mouse

Positive WB detected in:
mouse kidney tissue, HEK-293 cells, mouse heart tissue

Positive IP detected in:
mouse heart tissue

Positive IHC detected in:
human oesophagus cancer tissue, human heart tissue, human kidney tissue, human ovary tissue

Positive IF detected in:
HEK-293 cells, NIH/3T3 cells

Recommended dilution:
WB : 1:500-1:1000
IP : 0.5-4.0 ug for IP and 1:500-1:1000 for WB
IHC : 1:50-1:500
IF : 1:50-1:500

Product Information


Purification method:
Antigen affinity purification


PBS with 0.1% sodium azide and 50% glycerol pH 7.3. Store at -20oC. Aliquoting is unnecessary for -20oC storage.

Immunogen Information

Full name:
angiopoietin-like 4

Calculated molecular weight:
45 kDa

Observed molecular weight:
45-50 kDa

GenBank accession number:

Gene ID (NCBI):

Gene symbol

angiopoietin like 4, Angiopoietin like protein 4, Angiopoietin related protein 4, ANGPTL2, ANGPTL4, ARP4, FIAF, HFARP, NL2, PGAR, pp1158, PSEC0166, UNQ171/PRO197

Angiopoietin-like protein 4 (ANGPTL4), a member of the angiopoietin-like protein subfamily, is a secretory protein that functions as an important modulator of glucose and lipid metabolism. ANGPTL4 inhibits lipoprotein lipase (LPL)-dependent lipolysis thereby limiting the uptake of free fatty acids. Overexpression of ANGPTL4 results in hypertriglyceridemia, while ANGPTL4 deficiency suppresses foam formation in macrophages and protects against atherosclerosis. ANGPTL4 may play a role in several cancers and it also has been shown to prevent the metastatic process by inhibiting vascular activity as well as tumor cell motility and invasiveness. Decreased expression of this protein has been associated with type 2 diabetes.

to top